IPOs offer lucrative investment opportunities in the public market. Expert guidance, like that from Donovan Jones at IPO Edge, can reveal valuable insights. Accessing IPO filings and calendars is crucial…
Legend Biotech Corporation is becoming a significant player in the healthcare sector amidst financial strain and challenges like inflation and labor shortages. The U.S. healthcare technology market is expected to…
The White House is planning cuts in federal health agencies, risking jobs and impacting drug approvals and medical research. Eli Lilly is advancing its GLP-1 weight loss drug, orforglipron, into…
Andrea Pais transitioned from a small-town upbringing in India to cofounding Novel Microdevices, a medical diagnostics startup, highlighting the potential of pursuing one's dreams against the odds. Her journey emphasizes…
Thermo Fisher Scientific will lay off 300 employees by March 30 across Cambridge and Plainville. The layoffs come despite a reported 5% revenue increase for the fourth quarter of 2024.…
Frontier Medicines is streamlining its workforce to enhance operational efficiency and focus on high-impact therapies. Tough decisions, including layoffs, are deemed essential for maintaining a competitive edge in the biotech…
Valerio Therapeutics has suspended all clinical trials due to significant financial challenges. The company is pivoting towards early-stage projects while developing a single-chain antibody platform. Financial resources are projected to…
The EU Biotech and Biomanufacturing Hub aims to boost Europe's innovative capacity in biotechnology. Stéphane Séjourne emphasizes biotechnology as key to industrial innovation and sustainable productivity. The initiative includes crucial…
Legend Biotech is poised for a significant stock surge, with projections indicating a potential 129% increase by 2025. The company has achieved impressive growth, notably a year-over-year increase in net…
AbbVie is experiencing significant stock growth, reaching $183.90, driven by successful treatments like Humira and Skyrizi. Vertex Pharmaceuticals is gaining attention with shares at $461.68 and its innovative therapies for…